http://www.mmm-online.com/appointment/topic/22301/ Articles tagged with Appointment from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK's bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler http://www.mmm-online.com/business-briefs-shire-athenahealth-gsk-novartis/article/285898/ Mon, 25 Mar 2013 16:00:24 GMT Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK's bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler MMM Former Pfizer chieftain Hank McKinnell is taking the reins at stock scandal-plagued Optimer—perchance to sell it to Pfizer? http://www.mmm-online.com/ex-pfizer-chief-takes-over-at-troubled-optimer/article/282245/ Thu, 28 Feb 2013 05:23:45 GMT Former Pfizer chieftain Hank McKinnell is taking the reins at stock scandal-plagued Optimer—perchance to sell it to Pfizer? MMM The latest executive change has a touch of deja-vu: Novartis vet Jorg Reinhardt is returning from a stint at Bayer.The company also said it expects 2013 sales to be flat, but sees growth in 2014 and 2015. http://www.mmm-online.com/novartis-shakes-up-c-suite-as-sales-slide-3/article/277245/ Wed, 23 Jan 2013 17:31:10 GMT The latest executive change has a touch of deja-vu: Novartis vet Jorg Reinhardt is returning from a stint at Bayer.The company also said it expects 2013 sales to be flat, but sees growth in 2014 and 2015. MMM AstraZeneca jettisoned its global head of commercial operations and R&D chief, eliminating their roles and curtly suctioning off the company's second-highest layer of management. http://www.mmm-online.com/astrazeneca-shakeup-ousts-commercial-rd-chiefs/article/276162/ Tue, 15 Jan 2013 20:12:19 GMT AstraZeneca jettisoned its global head of commercial operations and R&D chief, eliminating their roles and curtly suctioning off the company's second-highest layer of management. MMM FDA's Jane Axelrad is leaving the Office of Regulatory Policy to head the agency's compounding policy rethink. http://www.mmm-online.com/fda-regulatory-policy-chief-to-take-on-compounding-question/article/273378/ Wed, 19 Dec 2012 21:15:27 GMT FDA's Jane Axelrad is leaving the Office of Regulatory Policy to head the agency's compounding policy rethink. MMM Mark Iwicki, previously president and CEO of Sepracor, has signed on as chief executive officer with oncology-focused pipeline biopharma Blend Therapeutics. http://www.mmm-online.com/ex-sepracor-chief-to-lead-startup-biotech/article/273167/ Wed, 19 Dec 2012 16:27:00 GMT Mark Iwicki, previously president and CEO of Sepracor, has signed on as chief executive officer with oncology-focused pipeline biopharma Blend Therapeutics. MMM Endo is on the hunt for a new President and CEO, Lundbeck lands a $50 million milestone payment and Lilly scales back a Phase III trial. http://www.mmm-online.com/company-news-endo-lundbeck-lilly/article/272546/ Thu, 13 Dec 2012 18:38:25 GMT Endo is on the hunt for a new President and CEO, Lundbeck lands a $50 million milestone payment and Lilly scales back a Phase III trial. MMM Teva names new president/CEO for Americas http://www.mmm-online.com/people-news-teva/article/267127/ Tue, 06 Nov 2012 16:56:51 GMT Teva names new president/CEO for Americas MMM